These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 18807631)

  • 21. beta-Blockade in noncardiac surgery: outcome at all levels of cardiac risk.
    Kaafarani HM; Atluri PV; Thornby J; Itani KM
    Arch Surg; 2008 Oct; 143(10):940-4; discussion 944. PubMed ID: 18936371
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Statins in practice of the vascular surgeon and cardiologist].
    Pokrovskiĭ AV; Suntsov DS
    Angiol Sosud Khir; 2009; 15(2):123-7. PubMed ID: 19806952
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of myocardial infarction from the patient.
    Rodgers KA
    N Z Med J; 1994 Apr; 107(975):140-1. PubMed ID: 7908426
    [No Abstract]   [Full Text] [Related]  

  • 24. [How should risk be reported?].
    Nielsen GL; Tage-Jensen U; Nielsen TT; Sørensen HT
    Ugeskr Laeger; 2005 Jan; 167(4):375-9. PubMed ID: 15719559
    [No Abstract]   [Full Text] [Related]  

  • 25. Primary prevention of vascular events in patients with high levels of C-reactive protein: the JUPITER study.
    Fonseca FA; Izar MC
    Expert Rev Cardiovasc Ther; 2009 Sep; 7(9):1041-56. PubMed ID: 19764857
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New clinical perspectives from nurses on aprotinin and fibrin sealants.
    Zoegall SG
    J Vasc Nurs; 2008 Dec; 26(4):100. PubMed ID: 19022167
    [No Abstract]   [Full Text] [Related]  

  • 27. Workshop on secondary prevention of myocardial infarction and stroke and management of cardiovascular risk.
    Mendis S
    Anadolu Kardiyol Derg; 2003 Dec; 3(4):366-7. PubMed ID: 14675893
    [No Abstract]   [Full Text] [Related]  

  • 28. Prasugrel: new drug. After angioplasty and stenting: continue to use aspirin + clopidogrel.
    Prescrire Int; 2009 Oct; 18(103):193-5. PubMed ID: 19877380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thiamine for the treatment of acute decompensated heart failure.
    Smithline HA
    Am J Emerg Med; 2007 Jan; 25(1):124-6. PubMed ID: 17157711
    [No Abstract]   [Full Text] [Related]  

  • 30. Serum levels of lipoprotein(a) and homocysteine in patients on hemodialysis who take hydroxymethylglutaryl-CoA reductase inhibitors, vitamin B6, and folic acid.
    Shojaei MH; Djalali M; Siassi F; Khatami MR; Boroumand MA; Eshragian MR
    Iran J Kidney Dis; 2009 Jul; 3(3):141-4. PubMed ID: 19617662
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Meta-analysis of adverse cardiovascular outcomes associated with antecedent hypertension after myocardial infarction.
    Chen G; Hemmelgarn B; Alhaider S; Quan H; Campbell N; Rabi D
    Am J Cardiol; 2009 Jul; 104(1):141-7. PubMed ID: 19576336
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does anticoagulation benefit patients with congestive heart failure (CHF) who have reduced left ventricular ejection fraction (LVEF) and are in normal sinus rhythm?
    Shah N; DeLeon D; Schwiebert LP; Mold JW
    J Okla State Med Assoc; 2009 Apr; 102(4):126-7. PubMed ID: 19504981
    [No Abstract]   [Full Text] [Related]  

  • 33. [Hemorrhagic complications of the digestive tract in heart diseases].
    Herman B; Hermanová K
    Gastroenterologia; 1965; 104(6):352-8. PubMed ID: 5295202
    [No Abstract]   [Full Text] [Related]  

  • 34. [Cardiovascular diseases and modern prospects for preventing stroke].
    Eliseev OM; Oshchepkova EV
    Ter Arkh; 2002; 74(9):73-8. PubMed ID: 12418127
    [No Abstract]   [Full Text] [Related]  

  • 35. The cost-effectiveness of implementing a new guideline for cardiovascular risk management in primary care in the Netherlands.
    Kok L; Engelfriet P; Jacobs-van der Bruggen MA; Hoogenveen RT; Boshuizen HC; Verschuren MW
    Eur J Cardiovasc Prev Rehabil; 2009 Jun; 16(3):371-6. PubMed ID: 19305351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Folic acid-based intervention in non-ST elevation acute coronary syndromes.
    Imasa MS; Gomez NT; Nevado JB
    Asian Cardiovasc Thorac Ann; 2009 Jan; 17(1):13-21. PubMed ID: 19515873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Labeling changes for cholesterol drug.
    FDA Consum; 2003; 37(4):8. PubMed ID: 12971338
    [No Abstract]   [Full Text] [Related]  

  • 38. Analysis of stroke in ATHENA: a placebo-controlled, double-blind, parallel-arm trial to assess the efficacy of dronedarone 400 mg BID for the prevention of cardiovascular hospitalization or death from any cause in patients with atrial fibrillation/atrial flutter.
    Connolly SJ; Crijns HJ; Torp-Pedersen C; van Eickels M; Gaudin C; Page RL; Hohnloser SH;
    Circulation; 2009 Sep; 120(13):1174-80. PubMed ID: 19752319
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes after stroke: risk of recurrent ischemic stroke and other events.
    Elkind MS
    Am J Med; 2009 Apr; 122(4 Suppl 2):S7-13. PubMed ID: 19332241
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of the Canadian Hypertension Education Programme in its first decade.
    McAlister FA; Feldman RD; Wyard K; Brant R; Campbell NR;
    Eur Heart J; 2009 Jun; 30(12):1434-9. PubMed ID: 19454575
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.